Digitisation | October 06, 2025
Roche’s AI-based kidney disease algorithm gains European certification
The new algorithm will be introduced as part of Roche’s CKD Algorithm Panelon thenavify Algorithm Suite
The new algorithm will be introduced as part of Roche’s CKD Algorithm Panelon thenavify Algorithm Suite
Hyperion results presented at ERS 2025 and simultaneously published in the New England Journal of Medicine
Health leaders rally for a national awakening on prevention, mental wellness, and lifestyle reform at ‘Illness to Wellness’ heart care conference
Zilebesiran, a potential best-in-disease RNAi anti-hypertensive with twice-yearly subcutaneous dosing, demonstrated encouraging safety when combined with two or more antihypertensives
Merck will share two oral presentations on ASCVD treatment patterns and patient burden
NATCO holds the first-to-file status for this product and will have 180-day generic drug exclusivity
Macitentan tablets are an endothelin receptor antagonist indicated for the treatment of pulmonary arterial hypertension
The company’s acquisition of a 51 per cent stake in Saarathi Healthcare earlier this financial year boosted growth
AINU is set to accelerate its expansion footprint, enhance operational capabilities
Finerenone significantly reduced the combined risk of cardiovascular death and total (first and recurrent) heart failure events,
Subscribe To Our Newsletter & Stay Updated
